Market Closed -
Canadian Securities Exchange
11:59:51 26/04/2024 pm IST
|
5-day change
|
1st Jan Change
|
0.055
CAD
|
0.00%
|
|
0.00%
|
+37.50%
|
Fiscal Period: März |
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
14.62
|
388.3
|
56.95
|
19.78
|
Enterprise Value (EV)
1 |
13.43
|
368.9
|
42.77
|
10.07
|
P/E ratio
|
-0.66
x
|
-38.5
x
|
-5.09
x
|
-2.66
x
|
Yield
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
-
|
51,76,87,873
x
|
-
|
EV / Revenue
|
-
|
-
|
38,88,06,055
x
|
-
|
EV / EBITDA
|
-43,61,444
x
|
-7,72,60,005
x
|
-45,83,503
x
|
-19,72,426
x
|
EV / FCF
|
-1,88,09,953
x
|
-12,88,79,352
x
|
-2,13,65,638
x
|
-35,82,306
x
|
FCF Yield
|
-0%
|
-0%
|
-0%
|
-0%
|
Price to Book
|
1.71
x
|
13.2
x
|
2.29
x
|
1.22
x
|
Nbr of stocks (in thousands)
|
2,43,691
|
3,26,288
|
3,79,638
|
3,29,653
|
Reference price
2 |
0.0600
|
1.190
|
0.1500
|
0.0600
|
Announcement Date
|
29/09/20
|
29/07/21
|
13/07/22
|
12/07/23
|
Fiscal Period: März |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
|
-
|
-
|
-
|
0.11
|
-
|
EBITDA
|
-
|
-3.08
|
-4.774
|
-9.331
|
-5.106
|
EBIT
1 |
-2.129
|
-3.141
|
-5.162
|
-9.742
|
-5.551
|
Operating Margin
|
-
|
-
|
-
|
-8,856.36%
|
-
|
Earnings before Tax (EBT)
1 |
-2.153
|
-18.84
|
-8.143
|
-9.709
|
-7.333
|
Net income
1 |
-2.153
|
-18.84
|
-8.143
|
-9.709
|
-7.442
|
Net margin
|
-
|
-
|
-
|
-8,826.36%
|
-
|
EPS
2 |
-0.0240
|
-0.0904
|
-0.0309
|
-0.0295
|
-0.0226
|
Free Cash Flow
|
-
|
-0.7142
|
-2.862
|
-2.002
|
-2.811
|
FCF margin
|
-
|
-
|
-
|
-1,819.77%
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
26/09/19
|
29/09/20
|
29/07/21
|
13/07/22
|
12/07/23
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
8.81
|
1.19
|
19.4
|
14.2
|
9.71
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-0.71
|
-2.86
|
-2
|
-2.81
|
ROE (net income / shareholders' equity)
|
-
|
-193%
|
-39.2%
|
-35.1%
|
-36.3%
|
ROA (Net income/ Total Assets)
|
-
|
-16.6%
|
-14.7%
|
-21.4%
|
-16.5%
|
Assets
1 |
-
|
113.9
|
55.32
|
45.35
|
45.09
|
Book Value Per Share
2 |
0.0600
|
0.0400
|
0.0900
|
0.0700
|
0.0500
|
Cash Flow per Share
2 |
0.0500
|
0.0100
|
0.0600
|
0.0400
|
0.0300
|
Capex
|
-
|
0.06
|
0.33
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
26/09/19
|
29/09/20
|
29/07/21
|
13/07/22
|
12/07/23
|
|
1st Jan change
|
Capi.
|
---|
| +37.50% | 13.24M | | +35.04% | 5.92B | | -15.13% | 4.51B | | -9.75% | 3.15B | | +2.14% | 3.1B | | -6.82% | 2.42B | | +47.87% | 1.97B | | -7.89% | 1.68B | | +0.09% | 1.65B | | -12.97% | 1.53B |
Alternative Medicine
|